WHO Suspends Hydroxychloroquine Trials Testing Its Use Against Covid-19

The organization coordinates trials with researchers from 100 countries, including Brazilians. The suspension occurs after a study with 96,000 patients found no effect against coronavirus and pointed to a higher risk of death.

RIO DE JANEIRO, BRAZIL - On Monday, May 25th, the World Health Organization (WHO) suspended the use of hydroxychloroquine in research it had been coordinating with scientists from 100 countries.

The temporary suspension was decided until the drug's safety is reassessed, since recent studies have shown that it is not effective against Covid-19 and may even increase the mortality rate.

The WHO says that the remaining trials are continuing within the international initiative called "Solidarity". In addition to the drug now vetoed, researchers are also evaluating the results of three types of antivirals and one drug used to treat . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?